Structural Biology of Human H3K9 Methyltransferases
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
UNLABELLED: SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity. ENHANCED VERSION: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Phylogenetic tree of human histone methyltransferases. Phylogeny is based on a multiple sequence alignment of the methyltransferase domain including the N-SET, Pre_SET, SET, I-SET, and Post-SET motifs. Substrate selectivity was extracted from Kouzarides [1]. Enzymes with solved structure are highlighted by a frame, dotted if no peptide substrate complex is available. Structures solved in the present work are framed in red.](https://figures.cochat.ai/paper-figures/f223740273dd4504943d435b9d71af7c/structural-biology-of-human-h3k9-methyltransferases-figure-1.jpg)

![Figure 3 Structural determinants of G9a mono/di-methylation specificity. A model of substrate lysine-bound G9a (Top panel) was generated from the superposition of the active sites of the GPL ternary complex and GLP. Y1067 of G9a stabilizes the di-methylamine end of the substrate lysine in an orientation where the lone-pair is not facing the co-factor, thereby disfavoring transfer of a third methyl group. The Y1067F mutant loses this restriction and can tri-methylate its substrate, as indicated in the table. Previous work had shown that the F1152Y G9a mutant can only mono-methylate H3K9 [29].](https://figures.cochat.ai/paper-figures/ecf8fd2d2aa84552bf80a968a979ba0d/structural-biology-of-human-h3k9-methyltransferases-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2008) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 87,804 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodCoot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 2×
“Graphics program COOT [36] was used for model building and PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8570 T a b le 1 .”
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903 · cited 1×
“. Tri-methylation of lysine 9 of histone 3 (H3K9) mediates chromatin recruitment of HP1, heterochromatin condensation and gene silencing”
BackgroundMethylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057 · cited 2×
“Methylation of histone tails is one of the fundamental events of epigenetic signaling [3].”
BackgroundSubstructure solution with SHELXD
Schneider, T. R., & Sheldrick, G. M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902011678 · Cited by 1,588 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodPartitioning and Plasticity of Repressive Histone Methylation States in Mammalian Chromatin
Peters, A. H. F. M., Kubicek, S., Mechtler, K., O'Sullivan, R. J., Derijck, A. A. H. A., Perez-Burgos, L., Kohlmaier, A., Opravil, S., Tachibana, M., Shinkai, Y., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00477-5 · Cited by 1,152 · cited 1×
“The specificity of PRDM2 is unknown [25].”
Heterochromatin and Epigenetic Control of Gene Expression
Grewal, S. I. S., & Moazed, D. (2003) · Science · doi:10.1126/science.1086887 · Cited by 1,065 · cited 1×
“Post-translational modifications of histone proteins regulate chromatin compaction, mediate epigenetic regulation of transcription, and control cellular differentiation in health and disease [1,2].”
BackgroundThe SET-domain protein superfamily: protein lysine methyltransferases.
Dillon, S. C., Zhang, X. Y., Trievel, R. C., & Cheng, X. (2005) · Genome biology · doi:10.1186/gb-2005-6-8-227 · Cited by 978 · cited 1×
“HKMTs catalyze the transfer of a methyl group from the co-factor S-adenosyl-Lmethionine (SAM) to a substrate lysine and, with the exception of DOT1L, are all organized around a canonical SET domain [7,8].”
Background
Cited by
Items 201–274 of 274
Regulation of the SUV39H Family Methyltransferases: Insights from Fission Yeast
Nakamura, R., & Nakayama, J. (2023) · Biomolecules · doi:10.3390/biom13040593 · Cited by 7
Efficient Hit-Finding Approaches for Histone Methyltransferases: The Key Parameters
Ahrens, T., Bergner, A., Sheppard, D. W., & Hafenbradl, D. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422823 · Cited by 6
“G9a is one of the best characterized HMTs and physiological functions, cellular substrates, structural information, and involvement in diseases and development of potent small-molecule inhibitors of the enzyme have been described.(18,22,47) We used G9a as a model HMT for a knowledge-based selection from the BioFocus c…”
MethodFan, L., Jiang, J., Gao, J., Song, H., Liu, J., Yang, L., Li, Z., Chen, Y., Zhang, Q., & Wang, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059097 · Cited by 7
Shi, X., An, Z., Cheng, S., Yao, J., Zhang, Y., Zhang, L., Cheng, X., Cui, Y., & Wang, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117135 · Cited by 5
Structural insights into binding of small molecule inhibitors to Enhancer of Zeste Homolog 2
Kalinić, M. D., Zloh, M., & Erić, S. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9788-1 · Cited by 5
Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2
Leenders, R. G. G., Zijlmans, R., van Bree, B., van de Sande, M., Trivarelli, F., Damen, E., Wegert, A., Müller, D., Ehlert, J. E., Feger, D., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.06.012 · Cited by 6
Hintzen, J. C. J., Merx, J., Maas, M. N., Langens, S. G. H. A., White, P. B., Boltje, T. J., & Mecinović, J. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob02191e · Cited by 5
Small molecule compounds targeting G9a/GLP: Recent advances and perspectives
Zhang, Q., Li, L., Li, S., & Zhou, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117525 · Cited by 5
Substrate recognition by the Pseudomonas aeruginosa EF-Tu–modifying methyltransferase EftM
Kuiper, E. G., Dey, D., LaMore, P. A., Owings, J. P., Prezioso, S. M., Goldberg, J. B., & Conn, G. L. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011213 · Cited by 5
“Similarly, EHMT1, which specifically mono- and dimethylates Lys-9 of histone H3 (H3K9), can recognize and methylate an 11-residue peptide from its target as the substrate, again with a mechanism consistent with the placement model (28).”
BackgroundQuinazolines as inhibitors of chromatin-associated proteins in histones
Herrera‐Vázquez, F. S., Hernández‐Luis, F., & Medina‐Franco, J. L. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02300-0 · Cited by 5
Camilli, F., Borrmann, A., Gholizadeh, S., Beek, T. A. H. T., Kuipers, R. K. P., & Venselaar, H. (2011) · EMBnet journal · doi:10.14806/ej.17.1.212 · Cited by 4
Update of the Methyltransferase Gene Family: Classification, Evolution and Biological Functions
Katsafadou, A. I., Falnes, P. Ø., Bruford, E. A., Braschi, B., Hanson, Q., Hall, M. D., Thompson, D. C., Nebert, D. W., & Vasiliou, V. (2026) · Human Genomics · doi:10.1186/s40246-026-00949-4 · Cited by 4
“In general, the H3K9 and H3K27 MTases facilitate heterochromatin formation and silence repetitive DNA sequences, ensuring transcriptional repression in specific genomic regions [38, 42, 43].”
Interaction of SET domains with histones and nucleic acid structures in active chromatin
Krajewski, W. A., & Vassiliev, O. L. (2011) · Clinical Epigenetics · doi:10.1007/s13148-010-0015-1 · Cited by 4
“…suggest that the target lysine residue accesses the cofactor S-adenosylmethionine, located on the opposite face of catalytic unit, through a narrow “trans-enzyme” lysineaccess channel, composed of hydrophobic residues (Bottomley 2004; Southall et al. 2009; Wu et al. 2010 and references therein).”
BackgroundPokorná, P., Krepl, M., & Šponer, J. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129771 · Cited by 3
Allele-Specific Chemical Rescue of Histone Demethylases Using Abiotic Cofactors
Scott, V., Dey, D., Kuwik, J., Hinkelman, K., Waldman, M., & Islam, K. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00335 · Cited by 4
Histone Methyltransferases: Opportunities in Cancer Drug Discovery
Chesworth, R., Wigle, T. J., Kuntz, K. W., Smith, J. J., & Richon, V. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-38404-2_9 · Cited by 3
Current Methods for Methylome Profiling
Luo, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801080-8.00010-7 · Cited by 4
Erika, D. Z., Bartollino, S., & Bruno, M. (2017) · Insights in Biology and Medicine · doi:10.29328/journal.hjbm.1001007 · Cited by 3
“In fact, the PR domain has diverged signi icantly from the SET domain [48-51] and most PR domains lack the H/RxxNHxC motif required for methyltransferase activity [52,53].”
BackgroundKamerzell, T. J., Mikell, B., Chen, L., Elias, H. K., Dawn, B., MacRae, C. A., & Middaugh, C. R. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.02.004 · Cited by 2
Investigation and design of the dual specificity of the PRDM9 protein lysine methyltransferase
Graf, D., Schnee, P., Pleiss, J., Weirich, S., & Jeltsch, A. (2025) · Communications Biology · doi:10.1038/s42003-025-08207-4 · Cited by 3
“These proteins are the outcome of divergent evolution 22,33 – 35 and many of them have been validated as PKMTs with a diverse set of histone and non-histone substrates.”
Activating Mutations of the EZH2 Histone Methyltransferase in Cancer
Kruger, R. G., Graves, A. P., & McCabe, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809737-3.00011-8 · Cited by 3
Pollin, G., de Assuncao, T. M., Jorge, S. D., Chi, Y., Charlesworth, M. C., Madden, B. J., Iovanna, J., Zimmermann, M. T., Urrutia, R. A., & Lomberk, G. A. (2023) · Bioscience Reports · doi:10.1042/bsr20231093 · Cited by 3
“…SETDB2, involved in silencing of retrotrans-posons, interspersed repetitive elements, and centromere-associated repeats, as well as EHMT1 (GLP) and EHMT2 (G9a), which are predominantly responsible for gene repression via H3K9 mono-and di-methylation (H3K9me1 and H3K9me2) at euchromatic loci [2].”
QM/MM MD and Free Energy Simulation Study of Methyl Transfer Processes Catalyzed by PKMTs and PRMTs
Chu, Y., & Guo, H. (2015) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-015-0280-y · Cited by 2
Macromolecular Interactome of Tetrahymena CHD Family Chromatin Remodelers
DeRango-Adem, E. (2017) · YorkSpace (York University) · Cited by 2
Assembling Ternary Dead-End Complex for Covalent Trapping of Protein Lysine Methyltransferases
Zong, Y., Zhang, N., Lin, J., Li, Z., Zou, Y., Chaudhuri, R., & Luo, M. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c14571 · Cited by 1
Diversity and functional specialization of H3K9‐specific histone methyltransferases
Koryakov, D. E. (2023) · BioEssays · doi:10.1002/bies.202300163 · Cited by 1
MetalKB: Predicting Metal Binding Sites on Proteins with a Knowledge-Based Graph Framework
Zhao, X., Li, H., & Huang, S.-Y. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00453 · Cited by 1
Emerging Epigenetic Therapies—Lysine Methyltransferase/PRC Complex Inhibitors
Pande, V., Pocalyko, D. J., & Dhanak, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00019-7 · Cited by 3
Morse, R. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-814809-9.00002-0 · Cited by 1
Facile synthesis of photoactivatable adenosine analogs
White, D. S., Mongeluzi, D. V., Curry, A. M., Donu, D., & Cen, Y. (2022) · RSC Advances · doi:10.1039/d1ra08794k · Cited by 1
Chromatin and viral integration in immunity: The challenge of silencing non-self genes
Kabi, M., & Filion, G. J. P. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.003 · Cited by 1
Désert, A., Guitot, K., Michaud, A., Holoch, D., Margueron, R., Burlina, F., & Guianvarc’h, D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2481-4_14 · Cited by 1
EZH2, the moderator in the discussion between methyltransferases at histone H3?
Cho, Y., Swarnabala, S., Lockey, R. F., & Kolliputi, N. (2014) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-014-0256-4 · Cited by 2
“Mono- and di-methylation by G9a/ GLP in H3K9 are linked to repression of certain histone and non-histone targets that are normally expressed in stem cells; G9a is also required for development of mouse embryo and differentiation of mouse embryonic stem cells (ESCs) (Wu et al. 2010; Chen et al. 2012; Fritsch et al. 201…”
Epigenetic Proteins as Emerging Drug Targets
Boriack‐Sjodin, P. A. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch18 · Cited by 1
Able, A. (2019) · Louisiana State University · doi:10.31390/gradschool_dissertations.5076 · Cited by 1
Functional analysis of the core subunits of Polycomb Repressive Complex 2
Nair, A. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Functional Characterization Of The Novel Prdm Gene Apox In Tribolium Castaneum
Wang, X. (2016) · Human Biology
New Insights into the Regulation of Hematopoietic Stem Cell Self-Renewal.
Jones, M. (2015) · Deep Blue (University of Michigan)
The Molecular Basis of Histone Methylation
Sun, L., & Fang, J. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-59786-7_6
Computational Modeling of Protein Structure, Function, and Binding Hotspots
Graham, S. E. (2017) · Deep Blue (University of Michigan)
Shields, K. M. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3034
“Y641 of EZH2 aligns with similar tyrosines in the active sites of other methyltransferases, including G9a and SETD7, and confers trimethylase activity to both these methyltransferases when mutated to phenylalanine or alanine (62,107).”
BackgroundPreez, D., & Lategan, L. (2018)
journal, E. (2011) · EMBnet journal · doi:10.14806/ej.17.1.242 · Cited by 4
Chromatin and epigenetic signaling pathways
Musselman, C. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813796-3.00001-8
QM/MM MD and free energy simulation study of methyl transfer processes catalyzed by PKMTs and PRMTs
Chu, Y., & Guo, H. (2015) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-014-0228-7
Çelik, M. A., Erdem, H., Çankaya, S., & Arıcı, Y. K. (2022) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_61_20 · Cited by 1
Proof-of-Concept Method to Study Uncharacterized Methyltransferases Using PRDM15
Zhao, L. N., Guccione, E., & Kaldis, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021327
“G9a and GLP catalyze the mono- and di-methylated states of histone H3K9 (H3K9me1 and H3K9me2) [30], and SUV39H2 causes the di- and tri-methylation of a mono-methylated lysine substrate [30].”
BackgroundInfluentialDiscovery of a Novel G9a-Selective Inhibitor for Hepatocellular Carcinoma Treatment
Mu, X., Li, J., Wei, R., Zhou, J., Ming, Y., Ma, H., Xu, F., Xu, X., Pu, W., & Peng, Y. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00444
Sécula, A., Bluy, L. E., Chapuis, H., Bonnet, A., Collin, A., Gress, L., Cornuez, A., Martin, X., Bodin, L., Bonnefont, C. M. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22609325
Yousefi, F., Simental, E., Du, Y., Whedon, S. D., Trnka, M. J., Darling, D., Jia, S., Panning, B., Cole, P. A., Halić, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.21.700667
“Both enzymes contain a “reader” domain; in this case, the aromatic cage is embedded in an ankyrin repeat domain (18) and a catalytic SET domain common to all histone methyltransferases (19).”
Biogenesis and Function of H3K9me3 at telomeres of mouse embryonic stem cells
Kan, S. (2015) · theses.fr (ABES) · doi:10.70675/cbaee4b0z64cez4b4eza882zbaf2c49e74a0
Etude du rôle des protéines Polycomb Pcgf1 et Ezh2 chez le poisson zèbre Danio rerio
Dupret, B. (2017) · theses.fr (ABES) · doi:10.70675/8f5fe7e1z5229z4a9eza0a5z877106bbd1be
“Ainsi les lncRNA comme les protéines sont régulés et jouent un rôle dans le devenir cellulaire (Wu et al. 2010).”
BackgroundComparaison des épigénomes des espèces non-modèles
Aliaga, B. (2018) · theses.fr (ABES) · doi:10.70675/94003e64z4244z46b6zba3cz1ba3691aac85
Berthelet, J. (2019) · theses.fr (ABES) · doi:10.70675/c500e9a8ze222z4b0czb01ez8ede9a4f765f
Glucocorticoid receptor activity in triple negative breast cancer
Noureddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/13ab50cfz7edbz4a44z918aza657b9614a4d · Cited by 1
Lu, A. Z., Haines, B. B., Zhang, W., Zhang, M., Whittington, D. A., Ji, L., Teng, T., Ferdinez, M. D., Yu, Y., Zhang, H., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-4720
Kiener, S., Rietmann, S. J., Soto, S., Ramos, S. J., Pucheu‐Haston, C. M., Wu, C., Wheatcraft, D., Simpson, A., Åhman, S., Wildermuth, B. E., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-59288-y
“Mammals have at least six H3K9 methylases that are able to catalyze the transfer of up to three methyl groups to H3K9 and thus initiate chromatin silencing 10,11 .”
Shah, T. V., Heidari, S., Rydzewski, J., & Torabifard, H. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c01817
Histone variants and their chaperones, in health and disease
Saettone, A., Morcos, S. M., & Campos, E. I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-19001-8.00020-9
Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies
Xu, Y., Wu, Q., Zhang, Y., Zhao, J., Fu, X., Li, A., & Li, Y. (2026) · Biomarker Research · doi:10.1186/s40364-026-01019-6
“These enzymes utilize S-adenosylmethionine (SAM) as a methyl donor to transfer methyl groups to the ε-amino group of H3K9, generating distinct methylation states (H3K9me1/2/3) [26].”
SET Domain Genes in Neurodevelopmental Disorders
Ohguri, A., Nakagawa, T., Nakagawa, M., & Hosoi, T. (2026) · Genes · doi:10.3390/genes17101313
“These proteins constitute distinct evolutionary branches characterized by different accessory-domain architectures [105–107] (Figure 5).”
BindingDB (2026) · UC San Diego · doi:10.7270/q2gh9ptk
BindingDB (2014) · UC San Diego · doi:10.7270/q2nz892t
BindingDB Entry 50020209: Structure-Activity Relationship Studies on Cell-Potent Nicotinamide
BindingDB (2024) · UC San Diego · doi:10.7270/q25m6b51
BindingDB Entry 50045464: SAH derived potent and selective EZH2 inhibitors.
BindingDB (2016) · UC San Diego · doi:10.7270/q2tm7css
BindingDB (2021) · UC San Diego · doi:10.7270/q2wd43vs
BindingDB Entry 50019206: Structure-Activity Relationship Studies of Venglustat on NTMT1 Inhibition.
BindingDB (2024) · UC San Diego · doi:10.7270/q2f47thb
BindingDB Entry 50021546: SETDB1 as a cancer target: challenges and perspectives in drug design.
BindingDB (2025) · UC San Diego · doi:10.7270/q2f47tsx
Metadata
- Authors
- Wu, H., Min, J., Lunin, V. V., Antoshenko, T., Dombrovski, L., Zeng, H., Allali-Hassani, A., Campagna-Slater, V., Vedadi, M., Arrowsmith, C. H., Plotnikov, A. N., & Schapira, M.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Plotnikov, Alexander N.
- Schapira, Matthieu
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-11
- Volume
- 5
- Issue
- 1
- Pages
- e8570
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2797608
- OpenAlex
- W2106473601
- Cited by
- 268
- References
- 39
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 11 · 2023: 14 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 17 · 2012: 21
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- GlaxoSmithKline
- Ontario Innovation Trust
- Genome Canada (1097737)
- Wellcome Trust (1097737)
- Ontario Genomics
- Ontario Genomics Institute
- Stiftelsen för Strategisk Forskning
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- H3K9 methyltransferase, SET domain, G9a, GLP, SUV39H2, PRDM2, histone methylation, epigenetic regulation, S-adenosylmethionine, induced fit, electrostatic interactions, protein structure
- MeSH terms
- Histone Methyltransferases, Crystallization, Humans, Models, Molecular, Protein Conformation, Histone-Lysine N-Methyltransferase, Substrate Specificity, Catalytic Domain, Static Electricity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.